(Q38518434)

5 November 2017

6 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

18 December 2020

25 October 2022

Formulation and pharmacology of long-acting cabotegravir (English)

1 reference

human immunodeficiency virus infectious disease

5 November 2017

5 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

Retroviridae infectious disease

1 reference

PubMed

RNA virus infectious disease

19 October 2019

1 reference

1 July 2020

1 reference

18 December 2020

Christine Trezza

1

1 reference

5 November 2017

Susan L Ford

2

1 reference

5 November 2017

William Spreen

3

1 reference

5 November 2017

Rennan Pan

4

1 reference

5 November 2017

Stephen Piscitelli

5

1 reference

5 November 2017

language of work or name

1 reference

1 July 2015

8 references

Current Opinion in HIV and AIDS

5 November 2017

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

25 October 2022

7 references

5 November 2017

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

25 October 2022

10

1 reference

5 November 2017

4

1 reference

5 November 2017

239-245

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

5 November 2017

7 references

23 March 2019

22 June 2019

19 October 2019

26 April 2020

1 July 2020

18 December 2020

on focus list of Wikimedia project

25 October 2022

ScienceSource

0 references

cites work

The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

GSK1265744 pharmacokinetics in plasma and tissue after single-dose long-acting injectable administration in healthy subjects

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxis.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Long-acting injectable antiretrovirals for HIV treatment and prevention

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Lack of pharmacokinetic interaction between rilpivirine and integrase inhibitors dolutegravir and GSK1265744.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Effects of etravirine on the pharmacokinetics of the integrase inhibitor S/GSK1265744.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Prevention of HIV-1 infection with early antiretroviral therapy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

Pharmacokinetics, safety, and tolerability with repeat doses of GSK1265744 and rilpivirine (TMC278) long-acting nanosuspensions in healthy adults

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5638427

10.1097/COH.0000000000000168

31 August 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference

5 November 2017

1 reference